Perlett_2023_Clin.Geriatr.Med_39_135

Reference

Title : Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias - Perlett_2023_Clin.Geriatr.Med_39_135
Author(s) : Perlett L , Smith EE
Ref : Clin Geriatr Med , 39 :135 , 2023
Abstract :

Ideally, dementia care should be provided by a collaborative team. Eligible patients should be treated with the cognitive-enhancing medications, the cholinesterase inhibitors and memantine. For most of the common causes of dementia, there are no disease-modifying medications, with the exception that vascular dementia can be prevented by treating vascular risk factors to prevent stroke. There is hope that Alzheimer disease can be treated by using monoclonal antibodies that target amyloid beta, although more trials are needed. Holistic, patient-centered care can enhance quality and extend the time that the patient can live safely in the community.

PubMedSearch : Perlett_2023_Clin.Geriatr.Med_39_135
PubMedID: 36404026

Related information

Citations formats

Perlett L, Smith EE (2023)
Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias
Clin Geriatr Med 39 :135

Perlett L, Smith EE (2023)
Clin Geriatr Med 39 :135